Severe Covid-19

被引:977
|
作者
Berlin, David A. [1 ]
Gulick, Roy M. [1 ]
Martinez, Fernando J. [1 ]
机构
[1] Weill Cornell Med, New York, NY 10065 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 25期
关键词
CONVALESCENT PLASMA; CHLOROQUINE;
D O I
10.1056/NEJMcp2009575
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with severe Covid-19 should have close monitoring for the need for endotracheal intubation; intubated patients should receive lung-protective ventilation. Data from randomized, controlled trials support a reduction in mortality with the use of dexamethasone and a reduction in time to clinical recovery with the use of remdesivir.
引用
收藏
页码:2451 / 2460
页数:10
相关论文
共 50 条
  • [21] Risk factors for severe COVID-19
    Gupta, Harish
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (09) : 2194 - 2195
  • [22] Mining a GWAS of Severe Covid-19
    Karim, Mohd
    Dunham, Ian
    Ghoussaini, Maya
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (26): : 2588 - 2589
  • [23] Tocilizumab for severe COVID-19 pneumonia
    Mourad, Jean-Jacques
    Azria, Philippe
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (11): : E659 - E659
  • [24] Reply to: Hypertension and severe COVID-19
    Shibata, Shigeru
    Asayama, Kei
    [J]. HYPERTENSION RESEARCH, 2023, 46 (05) : 1355 - 1355
  • [25] Respiratory Care for Severe COVID-19
    Prayag, Shirish
    [J]. INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2020, 24 (07) : 493 - 495
  • [26] Severe COVID-19 disease and thromboinflammation
    Jerjes-Sanchez, Carlos
    [J]. ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 (03): : 232 - 233
  • [27] REACTIVATION TB WITH SEVERE COVID-19
    Garg, Natasha
    Lee, Young Im
    [J]. CHEST, 2020, 158 (04) : 777A - 777A
  • [28] Severe Thrombocytopenia in a Patient with COVID-19
    Nham, Eliel
    Ko, Jae-Hoon
    Jeong, Byeong-Ho
    Huh, Kyungmin
    Cho, Sun Young
    Kang, Cheol-In
    Chung, Doo Ryeon
    Peck, Kyong Ran
    [J]. INFECTION AND CHEMOTHERAPY, 2020, 52 (03): : 410 - 414
  • [29] Impact of plasmapheresis on severe COVID-19
    Fonseca-Gonzalez, G.
    Alamilla-Sanchez, M.
    Garcia-Macas, V.
    Herrera-Acevedo, J.
    Villalobos-Brito, M.
    Tapia-Rangel, E.
    Maldonado-Tapia, D.
    Lopez-Mendoza, M.
    Cano-Cervantes, J. H.
    Orozco-Vazquez, J.
    Timaran-Montenegro, D.
    Cortes-Martinez, S.
    Escarela-Serrano, M.
    Munoz-Lopez, S.
    Montiel-Lopez, L.
    Mondragon-Teran, P.
    Suarez-Cuenca, J. A.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] Mavrilimumab for severe COVID-19 Reply
    De Luca, Giacomo
    Cavalli, Giulio
    Campochiaro, Corrado
    Della-Torre, Emanuel
    Dagna, Lorenzo
    [J]. LANCET RHEUMATOLOGY, 2020, 2 (11): : E662 - E663